RAPS.org needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site such as personalized content. Please see our Privacy Policy for more information.

Regulatory Manager: What Senior Management Needs to Know About CMC Regulatory Compliance for Biotech Products Part 4: At the Commercial Stage

| 01 November 2009

Congratulations-the biotech product has finally been approved! It has been a difficult struggle, but commercialization is now at hand. Senior management activities must shift to the buildup of adequate commercial inventories and market expansion opportunities for the biotech product.

© 2023 Regulatory Affairs Professionals Society.

Regulatory News

Story Thumbnail
FDA encourages RCTs in accelerated approval guidance for oncology
- 27 March 2023
Read More
Story Thumbnail
This Week at FDA: Becerra asks for new authorities; FDA issues guidances, reports
- 24 March 2023
Read More
Story Thumbnail
FDA outlines plan for digital health technologies for clinical trials
- 24 March 2023
Read More

Discover more of what matters to you

No taxonomy

News »

FDA proposes streamlining inspections office along with new human foods center

The evolution and use of patient-reported outcomes in regulatory decision making

Books »

Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective

Risk Management Principles for Devices and Pharmaceuticals, Third Edition

Learning »

China Drug Registration and Reimbursement (On-Demand)

Sponsored Webcast: UK Drug and Device Approvals Post Brexit (on-demand)

Events »

Artificial Intelligence Summit

Combination Products Summit 2023